| SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients A Algaissi, MA Alfaleh, S Hala, TS Abujamel, SS Alamri, SA Almahboub, ... Scientific reports 10 (1), 16561, 2020 | 102 | 2020 |
| Early humoral response correlates with disease severity and outcomes in COVID-19 patients AM Hashem, A Algaissi, SA Almahboub, MA Alfaleh, TS Abujamel, ... Viruses 12 (12), 1390, 2020 | 54 | 2020 |
| Synthetic SARS-CoV-2 spike-based DNA vaccine elicits robust and long-lasting th1 humoral and cellular immunity in mice SS Alamri, KA Alluhaybi, RY Alhabbab, M Basabrain, A Algaissi, ... Frontiers in microbiology 12, 727455, 2021 | 21 | 2021 |
| Cellular and humoral immunogenicity of a candidate DNA vaccine expressing SARS-CoV-2 spike subunit 1 KA Alluhaybi, RH Alharbi, RY Alhabbab, ND Aljehani, SS Alamri, ... Vaccines 9 (8), 852, 2021 | 12 | 2021 |
| SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients. Sci Rep 10: 16561 A Algaissi, MA Alfaleh, S Hala, TS Abujamel, SS Alamri, SA Almahboub, ... | 6 | 2020 |
| Generation of recombinant bioluminescent Escherichia coli for quantitative determination of bacterial adhesion. KA Rahman AlLuhaybi, GY Alghaith, NA Moneib, MA Magead Yassien Pakistan Journal of Pharmaceutical Sciences 28 (4), 2015 | 5 | 2015 |
| Enhanced immunogenicity of a synthetic DNA vaccine expressing consensus SARS-CoV-2 Spike protein using needle-free immunization SS Alamri, KA Alluhaybi, RY Alhabbab, A Algaissi, S Almahboub, ... bioRxiv, 2021.02. 01.429219, 2021 | 1 | 2021 |
| Multiple indirect ELISAs for serological detection of SARS-CoV-2 antibodies A Algaissi, MA Alfaleh, S Hala, TS Abujamel, SS Alamari, KA Alluhaybi, ... MDPI AG, 2020 | 1 | 2020 |
| Synthetic plasmid DNA vaccine expressing a codon-optimized SARS-COV-2 spike protein AM Hashem, MA Alfaleh, TS Abujamel, SS Alamri, A Algaissi, ... US Patent 11,607,449, 2023 | | 2023 |
| Synthetic plasmid dna vaccine expressing a codon-optimized sars-cov-2 spike protein and methods for its use AM Hashem, MA Alfaleh, TS Abujamel, SS Alamri, A Algaissi, ... US Patent App. 17/672,045, 2022 | | 2022 |
| Cellular and humoral immunogenicity of a candidate DNA Vaccine Expressing SARS-CoV-2 Spike Subunit 1 (preprint) KA Alluhaybi, RH Alharbi, RY Alhabbab, ND Aljehani, SS Alamri, ... | | 2021 |
| Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients (preprint) AM Hashem, A Algaissi, SA Almahboub, MA Alfaleh, TS Abujamel, ... | | 2020 |
